Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery
Open Access
- 1 November 2001
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 85 (5) , 386-390
- https://doi.org/10.1136/adc.85.5.386
Abstract
BACKGROUND AND AIMS The case fatality rate from meningococcal disease (MD) has remained relatively unchanged in the post antibiotic era, with 20–50% of patients who develop shock still dying. In 1992 a new paediatric intensive care unit (PICU) specialising in MD was opened. Educational information was disseminated to local hospitals, and a specialist transport service was established which delivered mobile intensive care. The influence of these changes on mortality of children with MD was investigated. METHODS A total of 331 consecutive children with meningococcal disease admitted to the PICU between 1992 and 1997 were studied. Severity of the disease on admission was assessed using the paediatric risk of mortality (PRISM) score. Logistic regression analysis was used to correct for clinical severity, age, and sex; death was the outcome, and year of admission, a temporal trend variable, was the primary exposure. RESULTS The case fatality rate fell year on year (from 23% in 1992/93 to 2% in 1997) despite disease severity remaining largely unchanged. After adjustment for age, sex, and disease severity, the overall estimate for improvement in the odds of death was 59% per year (odds ratio for the yearly trend 0.41). CONCLUSIONS A significant improvement in outcome for children admitted with MD to a PICU has occurred in association with improvements in initial management of patients with MD at referring hospitals, use of a mobile intensive care service, and centralisation of care in a specialist unit.Keywords
This publication has 21 references indexed in Scilit:
- Pathophysiology and Management of Meningococcal Septicaemia2000
- Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trialThe Lancet, 2000
- Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic ShockClinical Infectious Diseases, 1999
- Emergency management of meningococcal diseaseArchives of Disease in Childhood, 1999
- Differences in pediatric ICU mortality risk over timeCritical Care Medicine, 1998
- Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval teamBMJ, 1995
- Predictors of outcome in acute meningococcal infection in childrenCritical Care Medicine, 1993
- Stress ulcer prophylaxis and gastric alkalinization — death of a myth?Intensive Care Medicine, 1992
- Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987The Pediatric Infectious Disease Journal, 1989
- Pediatric risk of mortality (PRISM) scoreCritical Care Medicine, 1988